Clinical Trials
2 trialsNCT01215344 2018-05-15
First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00222053 2010-04-02
IFM 99-02 Thalidomide in Myeloma
University Hospital, Toulouse
Phase 3 Completed